Goto

Collaborating Authors

Brain chip deemed 'life-altering' after paralyzed men use it to control a computer with their MIND

Daily Mail - Science & tech

It may be the size of a paperclip, but this tiny brain implant has brought life back to men suffering with upper limb paralysis. Australia-based Synchron, a neurovascular bioelectronics medicine company, announced its Stentrode brain computer interface (BCI) has allowed patients to carry out tasks on a computer just by using their mind. Using the implant, patients achieved an average click accuracy of 92 percent and 93 percent and typing speeds of 14 and 20 characters per minute - without lifting a finger. The team is using blood vessels as a natural highway to the brain, which are laced with sensors that record activity. These signals are then sent through a telemetry unit to a small computer taped to the patient's chest, which interprets what actions the individual wants to perform on the nearby PC, such as texting, emailing and shopping online.


Brain chip allows paralysed man to post first ever 'direct-thought' tweet

The Independent - Tech

A paralysed man has made the first "direct-thought tweet" after having a computer chip implanted in his brain. Philip O-Keefe, a 62-year-old Australian who suffers from amyotrophic lateral sclerosis (ALS), composed and posted the tweet using only his thoughts via a brain computer interface developed by neurotech startup Synchron. I created this tweet just by thinking it," stated the tweet, which was posted to the account of Synchron CEO Thomas Oxley. After sharing the initial tweet, Mr O'Keefe posted seven further tweets replying to questions from Twitter users. "My hope is that I'm paving the way for people to tweet through thoughts," the final one stated. Follow live coverage of Nasa's James Webb Space Telescope launch James Webb Space Telescope successfully launched by Nasa Crypto experts make bitcoin price predictions for 2022 Follow live coverage of Nasa's James Webb Space Telescope launch The Stentrode device was first implanted in April 2020 after Mr O'Keefe's condition deteriorated to a point that he was unable to engage in work-related or other independent activities. It was inserted through the jugular vein in order to avoid invasive brain surgery, and has since allowed him to reconnect with loved ones and colleagues via email, as well as play simple computer-based gamed like Solitaire. "When I first heard about this technology, I knew how much independence it could give back to me," Mr O'Keefe said after posting the tweet, according to a press release from Synchron. "The system is astonishing, it's like learning to ride a bike – it takes practice, but once you're rolling, it becomes natural.


Elon Musk's Neuralink rival Synchron begins human trials of brain implant

Daily Mail - Science & tech

Elon Musk's Neuralink rival Synchron has begun human trials of its brain implant that lets the wearer control a computer using thought alone. The firm's Stentrode brain implant, about the size of a paperclip, will be implanted in six patients in New York and Pittsburgh who have severe paralysis. Stentrode will let patients control digital devices just by thinking and give them back the ability to perform daily tasks, including texting, emailing and shopping online. Although the implant has already been implanted and tested in Australian patients, the new clinical trial marks the first time it will be tested in the US. If successful, the Stentrode brain implant could be sold as a commercial product aimed at paralysis patients to regain their independence and quality of life.


New York company gets jump on Elon Musk's Neuralink with brain-computer interface in clinical trials

Daily Mail - Science & tech

Elon Musk might be well positioned in space travel and electric vehicles, but the world's second-richest person is taking a backseat when it comes to a brain-computer interface (BCI). New York-based Synchron announced Wednesday that it has received approval from the Food and Drug Administration to begin clinical trials of its Stentrode motor neuroprosthesis - a brain implant it is hoped could ultimately be used to cure paralysis. The FDA approved Synchron's Investigational Device Exemption (IDE) application, according to a release, paving the way for an early feasibility study of Stentrode to begin later this year at New York's Mount Sinai Hospital. New York-based Synchron announced Wednesday that it has received FDA approval to begin clinical trials of Stentrode, its brain-computer interface, beating Elon Musk's Neuralink to a crucial benchmark. The study will analyze the safety and efficacy of the device, smaller than a matchstick, in six patients with severe paralysis. Meanwhile, Musk has been touting Neuralink, his brain-implant startup, for several years--most recently showing a video of a monkey with the chip playing Pong using only signals from its brain.


Paralyzed Patients Use New Brain Stent and AI to Control Computer

#artificialintelligence

Scientists affiliated with the University of Melbourne and Synchron, Inc. published earlier this week in the Journal of NeuroInterventional Surgery the first-in-human study of Stentrode, a wireless neuroprosthesis that uses machine learning and a stent. What makes the Stentrode technology unique is that it is a stent that records brain activity inside a blood vessel in the brain. It is implanted through the jugular vein so there is no need for open brain surgery. The technology platform originated from the University of Melbourne, in a collaborative effort with the Royal Melbourne Hospital, the Florey Institute of Neuroscience and Mental Health, Monash University, and Synchron, Inc.. A brain-computer interface (BCI) enables two-way communications between the biological brain and a machine.